A Randomized Phase I Clinical Trial of HydroVax-YFV, a Novel Inativated Yellow Fever Vaccine
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
U44
-
Administering IC
AI
-
Application Type
4
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
999652
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
855
-
Ed Inst. Type
-
Funding ICs
NIAID:999652\
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZAI1
-
Study Section Name
Special Emphasis Panel